Life After Loeb: Ligand Pharmaceuticals Prospers In Stripped-Down ModeBiotech/Biopharma, Business, Layoffs, R&D, TherapeuticsOn his first day as chief executive of Ligand Pharmaceuticals in January 2007, John Higgins was shown into a conference room in the biotech firm’s 135,000-square-foot San Diego headquarters. Inside […] Read more July 1, 2015/by Forbes Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Forbes Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Forbes Health2015-07-01 03:00:002015-07-01 21:54:39Life After Loeb: Ligand Pharmaceuticals Prospers In Stripped-Down Mode